Aardvark Therapeutics, Inc Common Stock

Aardvark Therapeutics, Inc Common Stock

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-10
-11
-10
EBITDA
-19,717
-14,376
-21,577
-17,588
EBIT
-19,717
-14,387
-21,588
-17,598
Net Income
-19,186
-14,387
-21,588
-17,598
Net Change In Cash
0
0
0
0
Free Cash Flow
-13,536
-17,599
-18,869
-14,423
Cash
60,335
73,849
62,436
47,051
Basic Shares
21,886
21,846
21,815
21,815

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-36
-16
-97
-110
EBITDA
-57,555
-22,652
-6,556
-10,764
EBIT
-57,591
-22,668
-6,653
-10,874
Net Income
-57,591
-20,588
-7,208
-13,564
Net Change In Cash
0
0
0
0
Free Cash Flow
-54,267
-18,196
-5,824
-10,543
Cash
47,051
61,641
9,735
15,559
Basic Shares
21,815
21,695
21,384
21,384

Earnings Calls

QuarterEPS
2026-09-30
-$0.88
2026-06-30
-$0.66
2026-03-31
-$0.99
2025-12-31
-$0.81